Evidence map›Paper›PMID 19307030›Full record

ReviewTrends in neurosciences2009

Friends and foes in synaptic transmission: the role of tomosyn in vesicle priming.

Uri Ashery, Noa Bielopolski, Boaz Barak, Ofer Yizhar

Open access · greenAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. GPCR regulation of secretion.Pharmacology & therapeutics · 2018
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Uri AsheryDepartment of Neurobiology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. uria@post.tau.ac.il
Noa Bielopolski
Boaz Barak
Ofer Yizhar
Tel Aviv University · IL

Funding

Synaptic Plasticity In Aging And Neurodegenerative DisordersZIAAG000317 · NIA · NATIONAL INSTITUTE ON AGING · PI MATTSON, MARK · 2009 to 2018
$8.5M
Synaptic Plasticity In Aging And Neurodegenerative DisordersZ01AG000317 · NIA · NATIONAL INSTITUTE ON AGING · PI MATTSON, MARK P · 2001 to 2008
$1.7M
Regulation of tomosyn-SNARE complex assembly in neurosecretionR01NS053978 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STUENKEL, EDWARD L · 2006 to 2010
$1.6M
Intramural NIH HHS Z01 AG000317NINDS NIH HHS R01 NS053978
6 · The paper itself

Abstract

Priming is the process by which vesicles become available for fusion at nerve terminals and is modulated by numerous proteins and second messengers. One of the prominent members of this diverse family is tomosyn. Tomosyn has been identified as a syntaxin-binding protein; it inhibits vesicle priming, but its mode of action is not fully understood. The inhibitory activity of tomosyn depends on its N-terminal WD40-repeat domain and is regulated by the binding of its SNARE motif to syntaxin. Here, we describe new physiological information on the function of tomosyn and address possible interpretations of these results in the framework of the recently described crystal structure of the yeast tomosyn homolog Sro7. We also present possible molecular scenarios for vesicle priming and the involvement of tomosyn in these processes.

Indexed as

AnimalsHumansSynapsesSynaptic TransmissionSynaptic VesiclesVesicular Transport ProteinsVesicular Transport Proteins

Identifiers

PMID19307030
PMCPMC2713869
OpenAlexW1977468114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.